Circulating complement-C1q TNF-related protein 1 levels are increased in patients with type 2 diabetes and are associated with insulin sensitivity in Chinese subjects e94478

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Pan, Xuebo ^a   Lu, Tingting ^a   Wu, Fan ^b   Jin, Leigang ^a   Zhang, Yi ^a   Shi, Lihua ^a   Li, Xiaokun ^a,b   Lin, Zhuofeng ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; COMPLEMENT COMPONENT C1Q TUMOR NECROSIS FACTOR RELATED PROTEIN 1; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA PROTEIN; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, HUMAN; C1QTNF1 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; PROTEIN;

ADULT; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; UPREGULATION; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; ETHNOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADIPONECTIN; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; PROTEINS;

EID: 84901370223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094478     Document Type: Article

References (30)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749.
2. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, et al. (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102: 1296-1301.
3. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953. (Pubitemid 32756433)
4. Wong GW, Wang J, Hug C, Tsao TS, Lodish HF (2004) A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci U.S.A. 101: 10302-10307. (Pubitemid 38924920)
5. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, et al. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361: 226-228. (Pubitemid 36126226)
6. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, et al. (2003) Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52: 239-243. (Pubitemid 36173174)
7. Kishore U, Gaboriaud C, Waters P, Shrive AK, Greenhough TJ, et al. (2004) C1q and tumor necrosis factor superfamily: modularity and versatility. Trends immunol 25: 551-561. (Pubitemid 39208354)
8. Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GW (2012) Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem 287: 11968-11980.
9. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Revett T, Gimeno R, et al. (2008) Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J 416: 161-177.
10. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Ge G, Spooner E, et al. (2009) Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J 23: 241-258.
11. Peterson JM, Wei Z, Wong GW (2010) C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output. J Biol Chem 285: 39691-39701.
12. Kim KY, Kim HY, Kim JH, Lee CH, Kim DH, et al. (2006) Tumor necrosis factor-alpha and interleukin-1beta increases CTRP1 expression in adipose tissue. FEBS Lett 580: 3953-3960. (Pubitemid 43946893)
13. Peterson JM, Aja S, Wei Z, Wong GW (2012) CTRP1 protein enhances fatty acid oxidation via AMP-activated protein kinase (AMPK) activation and acetyl-CoA carboxylase (ACC) inhibition. J Biol Chem 287: 1576-1587.
14. Jeon JH, Kim KY, Kim JH, Baek A, Cho H, et al. (2008) A novel adipokine CTRP1 stimulates aldosterone production. FASEB J 22: 1502-1511. (Pubitemid 351656790)
15. Chalupova L, Zakovska A, Adamcova K (2013) Development of a novel enzyme-linked immunosorbent assay (ELISA) for measurement of serum CTRP1: a pilot study: measurement of serum CTRP1 in healthy donors and patients with metabolic syndrome. Clin Biochem 46: 73-78.
16. Lin Z, Wu Z, Yin X, Liu Y, Yan X, et al. (2010) Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. PLoS ONE 5: e15534.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
18. Li H, Bao Y, Xu A, Pan X, Lu J, et al. (2009) Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma- glutamyltransferase but not insulin sensitivity in Chinese subjects. J Clin Endocrinol Metab 94: 2151-2156.
19. Cederholm J, Wibell L (1990) Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Prac 10: 167-175. (Pubitemid 20350538)
20. Li Y, Chen M, Xuan H, Hu F (2012) Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus rats. Evid Based Complement Alternat Med: 981896.
21. Woo YC, Tso AW, Xu A, Law LS, Fong CH, et al. (2012) Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction. PLoS ONE 7: e36868.
22. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599. (Pubitemid 30353893)
23. Fernandez-Real JM, Castro A, Vazquez G, Casamitjana R, Lopez-Bermejo A, et al. (2004) Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes care 27: 739-745. (Pubitemid 38280543)
24. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, et al. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50: 1126-1133. (Pubitemid 32374544)
25. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, et al. (2013) Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome. PLoS ONE 8: e55744.
26. Hwang YC, Woo Oh S, Park SW, Park CY (2013) Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. Int J Obes (Lond). Doi:10.1038/ijo.2013.242. [Epub ahead of print].
27. Saltevo J, Kautiainen H, Vanhala M (2009). Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes. Gend Med. 6(3): 463-70.
28. Böttner A, Kratzsch J, Müller G, Kapellen TM, Blüher S, et al (2004). Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab. 89(8): 4053-61. (Pubitemid 39071513)
29. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946. (Pubitemid 32756432)
30. Peterson JM, Wei Z, Seldin MM, Byerly MS, Aja S, et al. (2013) CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. Am J Physiol Regul Integr Comp Physiol 305: R522-533.